1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Biopharmaceuticals Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Biopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Biopharmaceuticals Market Regional Analysis
6.2 North America Biopharmaceuticals Market Revenue 2020-2028 (US$ Billion)
6.3 North America Biopharmaceuticals Market Forecast Analysis
7. North America Biopharmaceuticals Market Analysis – by Product Type
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.2 Recombinant Vaccines
- 7.2.1 Overview
- 7.2.2 Recombinant Vaccines: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.3 Conventional Vaccines
- 7.3.1 Overview
- 7.3.2 Conventional Vaccines: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.4 Recombinant Growth Factors
- 7.4.1 Overview
- 7.4.2 Recombinant Growth Factors: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.5 Purified Proteins
- 7.5.1 Overview
- 7.5.2 Purified Proteins: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.6 Recombinant Proteins
- 7.6.1 Overview
- 7.6.2 Recombinant Proteins: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.7 Recombinant Hormones
- 7.7.1 Overview
- 7.7.2 Recombinant Hormones: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.8 Recombinant Enzymes
- 7.8.1 Overview
- 7.8.2 Recombinant Enzymes: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.9 Cell & Gene Therapies
- 7.9.1 Overview
- 7.9.2 Cell & Gene Therapies: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.10 Cytokines/Interferon/Interleukins
- 7.10.1 Overview
- 7.10.2 Cytokines/Interferon/Interleukins: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8. North America Biopharmaceuticals Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.2 Inflammatory & Infectious Disease
- 8.2.1 Overview
- 8.2.2 Inflammatory & Infectious Disease: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.3 Autoimmune Disorders
- 8.3.1 Overview
- 8.3.2 Autoimmune Disorders: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.4 Metabolic Disorders
- 8.4.1 Overview
- 8.4.2 Metabolic Disorders: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.5 Hormonal Disorders & Growth Failure
- 8.5.1 Overview
- 8.5.2 Hormonal Disorders & Growth Failure: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.6 Cardiovascular Diseases
- 8.6.1 Overview
- 8.6.2 Cardiovascular Diseases: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.7 Neurological Diseases
- 8.7.1 Overview
- 8.7.2 Neurological Diseases: North America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
9. North America Biopharmaceuticals Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Biopharmaceuticals Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 North America Biopharmaceuticals Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.1.1 US: North America Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.1.2 US: North America Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.2 Canada:
North America Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.2.1 Canada: North America Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.2.2 Canada: North America Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.3 Mexico :
North America Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.3.1 Mexico : North America Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.3.2 Mexico : North America Biopharmaceuticals Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 AbbVie Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AGC Biologics AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Amgen Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bristol-Myers Squibb Co
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Eli Lilly and Co
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Johnson & Johnson
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Lonza Group AG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 WuXi Biologics Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Biopharmaceuticals Market
